chr1-2406791-C-CT

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_002617.4(PEX10):​c.704dupA​(p.Leu236AlafsTer103) variant causes a frameshift change. The variant allele was found at a frequency of 0.00014 in 1,610,682 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

PEX10
NM_002617.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:12

Conservation

PhyloP100: 5.03
Variant links:
Genes affected
PEX10 (HGNC:8851): (peroxisomal biogenesis factor 10) This gene encodes a protein involved in import of peroxisomal matrix proteins. This protein localizes to the peroxisomal membrane. Mutations in this gene result in phenotypes within the Zellweger spectrum of peroxisomal biogenesis disorders, ranging from neonatal adrenoleukodystrophy to Zellweger syndrome. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-2406791-C-CT is Pathogenic according to our data. Variant chr1-2406791-C-CT is described in ClinVar as [Pathogenic]. Clinvar id is 6774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX10NM_002617.4 linkc.704dupA p.Leu236AlafsTer103 frameshift_variant Exon 4 of 6 ENST00000447513.7 NP_002608.1 O60683-1A0A024R068

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX10ENST00000447513.7 linkc.704dupA p.Leu236AlafsTer103 frameshift_variant Exon 4 of 6 1 NM_002617.4 ENSP00000407922.2 O60683-1

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152252
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000206
AC:
5
AN:
242276
Hom.:
0
AF XY:
0.0000152
AC XY:
2
AN XY:
131988
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000458
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000146
AC:
213
AN:
1458430
Hom.:
0
Cov.:
35
AF XY:
0.000127
AC XY:
92
AN XY:
725322
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000187
Gnomad4 OTH exome
AF:
0.0000664
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152252
Hom.:
0
Cov.:
33
AF XY:
0.0000807
AC XY:
6
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000793

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Peroxisome biogenesis disorder 6A (Zellweger) Pathogenic:3
Jul 22, 2016
Counsyl
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 01, 2010
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Mar 17, 2024
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Peroxisome biogenesis disorder 6B Pathogenic:2
Aug 01, 2010
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Jul 22, 2016
Counsyl
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:2
Oct 20, 2020
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Frameshift variant predicted to result in protein truncation as the last 91 amino acids are replaced with 102 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 21031596, 10862081, 17702006, 20695019) -

Nov 29, 2017
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

PEX10-related disorder Pathogenic:1
Jun 05, 2024
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

The PEX10 c.764dupA variant is predicted to result in a frameshift and premature protein termination (p.Leu256Alafs*103). This variant was found in a compound heterozygous state in three patients affected by peroxisomal biogenesis disorders (PBD) (Warren et al. 2000. PubMed ID: 10862081; Steinberg et al. 2004. PubMed ID: 15542397; Régal et al. 2010. PubMed ID: 20695019). This variant is reported in 0.0056% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in PEX10 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Peroxisome biogenesis disorder 6A (Zellweger);C3553948:Peroxisome biogenesis disorder 6B Pathogenic:1
Feb 06, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Zellweger spectrum disorders Pathogenic:1
Sep 16, 2020
Natera, Inc.
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Peroxisome biogenesis disorder, complementation group 7 Pathogenic:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Leu256Alafs*103) in the PEX10 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 91 amino acid(s) of the PEX10 protein. This variant is present in population databases (rs61750435, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Zellweger syndrome spectrum (PMID: 10862081, 17702006, 19105186, 20695019, 21031596). This variant is also known as c.704dupA, c.764_765insA or p.L256fsX102. ClinVar contains an entry for this variant (Variation ID: 6774). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects PEX10 function (PMID: 10862081, 20695019). For these reasons, this variant has been classified as Pathogenic. -

Peroxisome biogenesis disorder Pathogenic:1
Sep 14, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The PEX10 c.764dupA (p.Leu256AlafsX92+) variant causes a frameshift and is predicted to result in an elongation of the protein. One frameshift/elongation variant in PEX10 has been classified as pathogenic by our laboratory (e.g. c.874_875delCT, p.Leu292fsX55+). One in silico tool predicts a damaging outcome for this variant. One functional study showed less than 50% relative rescue activity compared to the wild type (Warren_2000). The variant was found in the control population dataset of ExAC in 2/93566 control chromosomes at a frequency of 0.0000214, which does not exceed the estimated maximal expected allele frequency of a pathogenic PEX10 variant (0.001118). This variant was reported in multiple Zellweger syndrome patients, in homozygotes and heterozygotes, including one case of uniparental disomy (Ebberink_2010, Turner_PEX10). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61750435; hg19: chr1-2338230; API